对肌萎缩侧索硬化复杂遗传学与病理生理学的新认识
本文综述肌萎缩侧索硬化(ALS)的遗传学与病理生理学进展。自1993年发现SOD1基因以来,新技术加速了多个新基因的发现,并深化了对寡基因和多基因疾病风险、基因-表型关联及共同失调通路分子步骤的理解。与ALS相关的突变适合基于基因的新疗法,暴露组通过基因-时间-环境假说成为重要影响因素,有望促成期待已久的疗法和可改变风险因素的识别。
要点
- ALS相关基因发现自1993年SOD1起逐步推进,近期遗传技术加速了多个新基因的识别。
- 对寡基因和多基因疾病风险的新认识加深,ALS基因与其他神经退行性疾病基因重叠揭示表型谱。
- ALS相关突变适合基于基因的新疗法,暴露组通过基因-时间-环境假说成为重要影响因素。
核心结论
- 对遗传结构、基因-表型关联、共同失调通路及暴露组的深入理解,将促成期待已久的疗法和可改变风险因素的识别。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 自1993年发现SOD1基因以来,ALS相关基因的发现起初较为渐进。
- 近期遗传技术进展快速识别了多个新的ALS相关基因。
- ALS相关基因与其他神经退行性疾病基因重叠,有助于理解神经退行性变的表型谱和基因型-表型关联。
- 对遗传结构认识的加深使得能够描述多种突变所致、汇聚于反复失调通路的分子步骤。
- ALS相关突变适合基于基因的新疗法,该策略已用于其他神经系统疾病。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease. The discovery of genes associated with amyotrophic lateral sclerosis, commencing with SOD1 in 1993, started fairly gradually. Recent advances in genetic technology have led to the rapid identification of multiple new genes associated with the disease, and to a new understanding of oligogenic and polygenic disease risk. The overlap of genes associated with amyotrophic lateral sclerosis with those of other neurodegenerative diseases is shedding light on the phenotypic spectrum of neurodegeneration, leading to a better understanding of genotype-phenotype correlations. A deepening knowledge of the genetic architecture is allowing the characterisation of the molecular steps caused by various mutations that converge on recurrent dysregulated pathways. Of crucial relevance, mutations associated with amyotrophic lateral sclerosis are amenable to novel gene-based therapeutic options, an approach in use for other neurological illnesses. Lastly, the exposome-the summation of lifetime environmental exposures-has emerged as an influential component for amyotrophic lateral sclerosis through the gene-time-environment hypothesis. Our improved understanding of all these aspects will lead to long-awaited therapies and the identification of modifiable risks factors.
引用
- Goutman SA, Hardiman O, Al-Chalabi A, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022. PMID: 35334234. doi:10.1016/S1474-4422(21)00414-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。